Chinazoline derivatives as aurora kinase inhibitors

Details for Australian Patent Application No. 2004249477 (hide)

Owner AstraZeneca AB

Inventors Jung, Frederic Henri; Heron, Nicola Murdoch; Mortlock, Andrew Austen

Agent Davies Collison Cave

Pub. Number AU-A-2004249477

PCT Pub. Number WO2004/113324

Priority 03291463.2 17.06.03 EP

Filing date 14 June 2004

Wipo publication date 29 December 2004

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/113324 Priority application(s): WO2004/113324

11 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249483-Amine salts of (-)-2-{`2-(4-hydroxyphenyl) ethyl!-thio}-3-`4-(2-{4-`(methylsulfonyl)o xy! phenoxy}ethyl)phenyl! propanoic acid and there use in medicine

2004249474-Therapeutic agents